PrimeRFP SCOUT · Federal Contract Recompete Brief · 8(a) STARS III

75F40122F80355BIMO program (under covid) subject MATTER — Sagacity Ventures LLC

Sagacity Ventures LLC holds $3.7M across 4 federal awards, concentrated at General Services Administration (GSA). This PIID sits alongside 1 related award under parent 47QTCB21D0429. The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended Sep 26, 2023 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Fda Office Of Acq Grant Svcs

Awarding office

Sagacity Ventures LLC

Recipient

Sep 26, 2023

PoP end

$2.3M

Obligated

$2.3M

Potential

541512

NAICS

R408

PSC

8(a) STARS III

Vehicle

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Sagacity Ventures LLC — $90

Contract facts

Federal

Contract number75F40122F80355

Also listed as47QTCB21D0429-75F40122F80355

AgencyFda Office Of Acq Grant Svcs

Awarding officeFda Office Of Acq Grant Svcs

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentSagacity Ventures LLC

CAGE8P8L5

UEIH1S1ULWVRYK8

NAICS541512

PSCR408

Vehicle8(a) STARS III

Parent IDIQ / IDV47QTCB21D0429

Place of performanceALEXANDRIA VA

Pricing typeLabor Hours

Extent competedFull And Open Competition After Exclusion Of Sources

PoP startSep 12, 2022

PoP end (current)Sep 26, 2023

Obligated$2.3M

Current value$2.3M

Potential value$2.3M

BIMO PROGRAM (UNDER COVID) SUBJECT MATTER EXPERTISE SUPPORT is a federal award for Fda Office Of Acq Grant Svcs held by Sagacity Ventures LLC. Estimated value $2.3M ($2.3M obligated). Current period of performance ends Sep 26, 2023. Last award drew 1 bidder. Place of performance: ALEXANDRIA VA.

BIMO PROGRAM (UNDER COVID) SUBJECT MATTER EXPERTISE SUPPORT

Recompete timing

Public

● Past PoP end (1060 days ago)

Current PoP ended Sep 26, 2023 (1060 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Sagacity Ventures LLC — $3.7M obligated across 4 awards (firm-wide, all agencies) · lead buyer General Services Administration (GSA).

% of firm-wide obligated ($3.7M) · all agencies

General Services Administration (GSA)$3.4M · 92%Department of Health and Human Services (HHS)$251K · 7%

Open full company profile →

Related awards

Same parent · incumbent

47HAA024F0125

DIRECT 8(A) AWARD FOR OHRM TECHNICAL PROGRAM MANAGEMENT SUPPORT SERVICES

$3.4M

Oct 4, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75F40122F80355?

75F40122F80355 (BIMO program (under covid) subject MATTER) is a Fda Office Of Acq Grant Svcs award with a potential value of $2.3M, currently held by Sagacity Ventures LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40122F80355?

Fda Office Of Acq Grant Svcs awarded 75F40122F80355 to Sagacity Ventures LLC (potential $2.3M).

Who is the incumbent on 75F40122F80355?

Sagacity Ventures LLC is the incumbent with $3.7M across 4 related awards in SCOUT’s public footprint. The current period of performance ends Sep 26, 2023.

When does Sagacity Ventures LLC’s 75F40122F80355 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 26, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Sep 23, 2025